UroGen Pharma Ltd. (URGN)
Company Info
Highlights
$456.60M
-$3.02
$65.83M
$59.42M
-$65.65M
$9.78 - $20.70
$36.71
14.94%
16.60
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in UroGen Pharma Ltd., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
UroGen Pharma Ltd. had a return of 1.60% year-to-date (YTD) and -43.76% in the last 12 months.
URGN
1.60%
5.36%
-27.24%
-43.76%
-18.67%
N/A
^GSPC (Benchmark)
4.46%
2.46%
9.31%
23.49%
13.03%
11.31%
Monthly Returns
The table below presents the monthly returns of URGN, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 3.38% | 1.60% | |||||||||||
| 2024 | 4.67% | 16.75% | -18.17% | -7.87% | -3.76% | 26.17% | -1.97% | -15.44% | -8.70% | -3.46% | 3.59% | -16.14% | -29.00% |
| 2023 | 17.14% | -0.87% | -10.29% | 25.43% | -14.58% | 4.55% | 109.28% | -19.30% | -19.85% | -19.99% | 17.66% | 13.72% | 69.11% |
| 2022 | -18.82% | -22.28% | 45.17% | -18.94% | -24.65% | 53.95% | -4.27% | -4.97% | 11.68% | 42.43% | -27.68% | 3.50% | -6.73% |
| 2021 | 22.48% | -13.68% | 2.26% | -0.15% | -9.41% | -13.34% | 1.51% | 13.68% | -4.54% | 2.26% | -29.71% | -21.34% | -47.23% |
| 2020 | -11.87% | -7.31% | -34.56% | 24.50% | 5.67% | 11.29% | -15.43% | 13.58% | -23.12% | 16.74% | -7.86% | -13.16% | -46.00% |
| 2019 | -3.81% | -7.10% | -4.00% | -2.68% | -5.26% | 5.52% | -5.12% | -0.44% | -29.81% | -5.04% | 39.81% | 5.47% | -22.50% |
| 2018 | 32.01% | 7.21% | -5.64% | 12.74% | 7.32% | -17.23% | -9.16% | 6.92% | -2.28% | -15.50% | 22.88% | -12.19% | 15.72% |
| 2017 | 27.68% | 1.18% | 0.55% | 31.33% | 32.16% | 0.67% | 27.23% | -7.83% | 166.17% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of URGN is 14, meaning it’s performing worse than 86% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for UroGen Pharma Ltd. (URGN) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the UroGen Pharma Ltd.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the UroGen Pharma Ltd. was 92.16%, occurring on May 25, 2022. The portfolio has not yet recovered.
The current UroGen Pharma Ltd. drawdown is 83.44%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -92.16% | May 21, 2018 | 1012 | May 25, 2022 | — | — | — |
| -20.07% | May 31, 2017 | 12 | Jun 15, 2017 | 7 | Jun 26, 2017 | 19 |
| -18.48% | Jan 26, 2018 | 7 | Feb 5, 2018 | 19 | Mar 5, 2018 | 26 |
| -16.63% | Sep 15, 2017 | 26 | Oct 20, 2017 | 9 | Nov 2, 2017 | 35 |
| -15.97% | Mar 15, 2018 | 12 | Apr 2, 2018 | 1 | Apr 3, 2018 | 13 |
Volatility
Volatility Chart
The current UroGen Pharma Ltd. volatility is 11.87%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for UroGen Pharma Ltd..
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |